Compugen
CGEN
#8898
Rank
$0.14 B
Marketcap
$1.51
Share price
-6.21%
Change (1 day)
-4.43%
Change (1 year)

Revenue for Compugen (CGEN)

Revenue in 2025 (TTM): $6.9 Million USD

According to Compugen's latest financial reports the company's current revenue (TTM ) is $6.9 Million USD. In 2024 the company made a revenue of $27.86 Million USD a decrease over the revenue in the year 2023 that were of $33.45 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Compugen from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $6.9 M-75.23%
2024 $27.86 M-16.72%
2023 $33.45 M346.12%
2022 $7.5 M25%
2021 $6 M200%
2020 $2 M
2019 N/A-100%
2018 $17.8 M
2017 N/A-100%
2016 $0.71 M-92.33%
2015 $9.27 M-24.98%
2014 $12.36 M248.46%
2013 $3.54 M1366.53%
2012 $0.24 M
2011 N/A-100%
2010 $1.11 M346%
2009 $0.25 M-26.04%
2008 $0.33 M
2004 $4.02 M-54.37%
2003 $8.82 M-20.46%
2002 $11.09 M-2.32%
2001 $11.36 M56.5%
2000 $7.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
$2.30 B 33,223.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$16.77 B 242,924.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Genetic Technologies
GENE
$17.1 M 147.76%๐Ÿ‡ฆ๐Ÿ‡บ Australia